SERIES A / SERIES B COMMON STOCK PURCHASE WARRANT DERMATA THERAPEUTICS, INC.Dermata Therapeutics, Inc. • September 17th, 2024 • Pharmaceutical preparations • New York
Company FiledSeptember 17th, 2024 Industry JurisdictionTHIS SERIES A / SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [___]1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2024 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 17th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 16, 2024, between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 17th, 2024 • Dermata Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 17th, 2024 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of September 16, 2024, by and between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).